story of the week
Intravenous NEPA for Prevention of CINV in Patients With Breast Cancer Receiving AC Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients With Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy
Oncologist 2019 Dec 04;[EPub Ahead of Print], L Schwartzberg, R Navari, R Clark-Snow, E Arkania, I Radyukova, K Patel, D Voisin, G Rizzi, R Wickham, RJ Gralla, M Aapro, E RoelandFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.